This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications.

This guideline includes recommendations on:

communication and support; laboratory investigations; imaging investigations; managing newly-diagnosed and relapsed myeloma; preventing and managing bone disease and other complications; and monitoring.